{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:44:48Z","timestamp":1790318688559,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is the most frequently diagnosed malignancy among men and presents major clinical and socioeconomic challenges worldwide. Despite advances in early detection, imaging, and therapy, managing PCa remains complex due to disease heterogeneity, risks of overdiagnosis, and overtreatment. Digital twin (DT) technologies might represent an emerging conceptual framework aimed at supporting dynamic, patient-specific virtual modeling for personalized clinical decision-making. By integrating multimodal clinical, imaging, molecular, and physiological data, DTs can simulate disease progression, predict treatment responses, and support proactive, adaptive care. This perspective explores the conceptual framework for DT ecosystems in PCa, highlighting potential clinical impacts, infrastructural requirements, and barriers to implementation. Harnessing DTs could impact PCa management into a truly predictive, personalized, and participatory approach, improving outcomes and optimizing healthcare resource utilization globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance statement<\/jats:title>\n                    <jats:p>DT technologies may enable personalized, predictive PCa management by integrating multimodal patient data to guide diagnosis, treatment selection, and monitoring, with the potential to improve outcomes, reduce overtreatment, and optimize healthcare resource utilization<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>DTs create virtual patient models to personalize PCa care.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>They integrate imaging, clinical, and molecular data into one system.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>This approach may reduce overdiagnosis and unnecessary treatments.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-026-00753-8","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:43:18Z","timestamp":1781880198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Digital twin technologies in prostate cancer as a frontier for precision medicine"],"prefix":"10.1186","volume":"10","author":[{"given":"Martina","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Laschena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Blasilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tronci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-918X","authenticated-orcid":false,"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"753_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"753_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, Van Den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86:148\u2013163. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","journal-title":"Eur Urol"},{"key":"753_CR3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Moore CM, Chiong E et al (2021) Prostate cancer. Lancet 398:1075\u20131090. https:\/\/doi.org\/10.1016\/S0140-6736(21)00950-8","journal-title":"Lancet"},{"key":"753_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J et al (2024) The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet 403:1683\u20131722. https:\/\/doi.org\/10.1016\/S0140-6736(24)00651-2","journal-title":"Lancet"},{"key":"753_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA et al (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77:38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005","journal-title":"Eur Urol"},{"key":"753_CR6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3390\/jcm10112459","volume":"10","author":"A Patasius","year":"2021","unstructured":"Patasius A, Smailyte G (2021) All-cause mortality risk in national prostate cancer cohort: an impact of population-based prostate cancer screening. J Clin Med 10:2459. https:\/\/doi.org\/10.3390\/jcm10112459","journal-title":"J Clin Med"},{"key":"753_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/jpm14010084","volume":"14","author":"K Beyer","year":"2024","unstructured":"Beyer K, Leenen R, Venderbos LDF et al (2024) Health policy for prostate cancer early detection in the European Union and the impact of opportunistic screening: PRAISE-U consortium. J Pers Med 14:84. https:\/\/doi.org\/10.3390\/jpm14010084","journal-title":"J Pers Med"},{"key":"753_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2023.08.002","volume":"84","author":"H Van Poppel","year":"2023","unstructured":"Van Poppel H, Roobol MJ, Chandran A (2023) Early detection of prostate cancer in the european union: combining forces with PRAISE-U. Eur Urol 84:519\u2013522. https:\/\/doi.org\/10.1016\/j.eururo.2023.08.002","journal-title":"Eur Urol"},{"key":"753_CR9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"key":"753_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","volume":"77","author":"F-JH Drost","year":"2020","unstructured":"Drost F-JH, Osses D, Nieboer D et al (2020) Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis. Eur Urol 77:78\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2019.06.023","journal-title":"Eur Urol"},{"key":"753_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s41747-025-00595-w","volume":"9","author":"SJ Riederer","year":"2025","unstructured":"Riederer SJ, Borisch EA, Froemming AT et al (2025) Improved image quality and reduced acquisition time in prostate T2-weighted spin-echo MRI using a modified PI-RADS-adherent sequence. Eur Radiol Exp 9:55. https:\/\/doi.org\/10.1186\/s41747-025-00595-w","journal-title":"Eur Radiol Exp"},{"key":"753_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019182946","volume":"292","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Barentsz J, Villeirs G et al (2019) PI-RADS steering committee: the PI-RADS multiparametric MRI and MRI-directed biopsy pathway. Radiology 292:464\u2013474. https:\/\/doi.org\/10.1148\/radiol.2019182946","journal-title":"Radiology"},{"key":"753_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41747-025-00584-z","volume":"9","author":"JN Gloe","year":"2025","unstructured":"Gloe JN, Borisch EA, Froemming AT et al (2025) Deep learning for quality assessment of axial T2-weighted prostate MRI: a tool to reduce unnecessary rescanning. Eur Radiol Exp 9:44. https:\/\/doi.org\/10.1186\/s41747-025-00584-z","journal-title":"Eur Radiol Exp"},{"key":"753_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ et al (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25:879\u2013887. https:\/\/doi.org\/10.1016\/S1470-2045(24)00220-1","journal-title":"Lancet Oncol"},{"key":"753_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA et al (2016) 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa1606220","journal-title":"N Engl J Med"},{"key":"753_CR16","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","volume":"364","author":"A Bill-Axelson","year":"2011","unstructured":"Bill-Axelson A, Holmberg L, Ruutu M et al (2011) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 364:1708\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1011967","journal-title":"N Engl J Med"},{"key":"753_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41747-023-00402-4","volume":"8","author":"I Van Den Berg","year":"2024","unstructured":"Van Den Berg I, Spaans RN, Wessels FJ et al (2024) Automated pelvic MRI measurements associated with urinary incontinence for prostate cancer patients undergoing radical prostatectomy. Eur Radiol Exp 8:1. https:\/\/doi.org\/10.1186\/s41747-023-00402-4","journal-title":"Eur Radiol Exp"},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(15)01037-5","volume":"387","author":"ND James","year":"2016","unstructured":"James ND, Sydes MR, Clarke NW et al (2016) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 387:1163\u20131177. https:\/\/doi.org\/10.1016\/S0140-6736(15)01037-5","journal-title":"Lancet"},{"key":"753_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.eururo.2020.01.012","volume":"77","author":"S Gillessen","year":"2020","unstructured":"Gillessen S, Attard G, Beer TM et al (2020) Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019. Eur Urol 77:508\u2013547. https:\/\/doi.org\/10.1016\/j.eururo.2020.01.012","journal-title":"Eur Urol"},{"key":"753_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1903835","volume":"381","author":"ID Davis","year":"2019","unstructured":"Davis ID, Martin AJ, Stockler MR et al (2019) Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med 381:121\u2013131. https:\/\/doi.org\/10.1056\/NEJMoa1903835","journal-title":"N Engl J Med"},{"key":"753_CR21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/annonc\/mdy071","volume":"29","author":"CL Vale","year":"2018","unstructured":"Vale CL, Fisher DJ, White IR et al (2018) What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis. Ann Oncol 29:1249\u20131257. https:\/\/doi.org\/10.1093\/annonc\/mdy071","journal-title":"Ann Oncol"},{"key":"753_CR22","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","volume":"28","author":"JN Acosta","year":"2022","unstructured":"Acosta JN, Falcone GJ, Rajpurkar P, Topol EJ (2022) Multimodal biomedical AI. Nat Med 28:1773\u20131784. https:\/\/doi.org\/10.1038\/s41591-022-01981-2","journal-title":"Nat Med"},{"key":"753_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","volume":"7","author":"E Katsoulakis","year":"2024","unstructured":"Katsoulakis E, Wang Q, Wu H et al (2024) Digital twins for health: a scoping review. NPJ Digit Med 7:77. https:\/\/doi.org\/10.1038\/s41746-024-01073-0","journal-title":"NPJ Digit Med"},{"key":"753_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/wics.70041","volume":"17","author":"K Jain","year":"2025","unstructured":"Jain K, Agarwal A, Agrawal S, Aggarwal A (2025) Digital twins in modern healthcare: a comprehensive review of architectures, applications, and challenges. WIREs Comput Stats 17:e70041. https:\/\/doi.org\/10.1002\/wics.70041","journal-title":"WIREs Comput Stats"},{"key":"753_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12553-024-00869-0","volume":"14","author":"S M","year":"2024","unstructured":"M S, S P, Veluvolu KC, Raman R (2024) An insight in the future of healthcare: integrating digital twin for personalized medicine. Health Technol 14:649\u2013661. https:\/\/doi.org\/10.1007\/s12553-024-00869-0","journal-title":"Health Technol"},{"key":"753_CR26","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.3390\/app14209404","volume":"14","author":"M \u0141ukaniszyn","year":"2024","unstructured":"\u0141ukaniszyn M, Majka \u0141, Grochowicz B et al (2024) Digital twins generated by artificial intelligence in personalized healthcare. Appl Sci 14:9404. https:\/\/doi.org\/10.3390\/app14209404","journal-title":"Appl Sci"},{"key":"753_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41746-025-01890-x","volume":"8","author":"D Camacho-Gomez","year":"2025","unstructured":"Camacho-Gomez D, Borau C, Garcia-Aznar JM et al (2025) Physics-informed machine learning digital twin for reconstructing prostate cancer tumor growth via PSA tests. NPJ Digit Med 8:485. https:\/\/doi.org\/10.1038\/s41746-025-01890-x","journal-title":"NPJ Digit Med"},{"key":"753_CR28","unstructured":"EDITH. Building the European Virtual Human Twin. Available via https:\/\/www.edith-csa.eu\/wp-content\/uploads\/2023\/04\/EDITH_D3.1_vision_roadmap_outline_final.pdf. Accessed 23 Jul 2024"},{"key":"753_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bmt.2023.02.001","volume":"4","author":"A Haleem","year":"2023","unstructured":"Haleem A, Javaid M, Pratap Singh R, Suman R (2023) Exploring the revolution in healthcare systems through the applications of digital twin technology. Biomed Technol 4:28\u201338. https:\/\/doi.org\/10.1016\/j.bmt.2023.02.001","journal-title":"Biomed Technol"},{"key":"753_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41746-024-01146-0","volume":"7","author":"M Shen","year":"2024","unstructured":"Shen M, Chen S, Ding X (2024) The effectiveness of digital twins in promoting precision health across the entire population: a systematic review. NPJ Digit Med 7:145. https:\/\/doi.org\/10.1038\/s41746-024-01146-0","journal-title":"NPJ Digit Med"},{"key":"753_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2025.108804","volume":"268","author":"A John","year":"2025","unstructured":"John A, Alhajj R, Rokne J (2025) A systematic review of AI as a digital twin for prostate cancer care. Comput Methods Prog Biomed 268:108804. https:\/\/doi.org\/10.1016\/j.cmpb.2025.108804","journal-title":"Comput Methods Prog Biomed"},{"key":"753_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2025.1614235","volume":"16","author":"GS Stamatakos","year":"2025","unstructured":"Stamatakos GS, Perez MA, Radhakrishnan R (2025) Editorial: multiscale cancer modeling, in silico oncology and digital (virtual) twins in the cancer domain. Front Physiol 16:1614235. https:\/\/doi.org\/10.3389\/fphys.2025.1614235","journal-title":"Front Physiol"},{"key":"753_CR33","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.3390\/app12168156","volume":"12","author":"J-K Kim","year":"2022","unstructured":"Kim J-K, Lee S-J, Hong S-H, Choi I-Y (2022) Machine-learning-based digital twin system for predicting the progression of prostate cancer. Appl Sci 12:8156. https:\/\/doi.org\/10.3390\/app12168156","journal-title":"Appl Sci"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-026-00753-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:43:20Z","timestamp":1781880200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41747-026-00753-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1186\/s41747-026-00753-8","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}